Patents by Inventor Gregory R. Halverson

Gregory R. Halverson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Systems and methods for determining antibody-mediated risk index
    Patent number: 9052325
    Abstract: Systems and methods are provided for assessing the risk of hemolytic disease of the fetus or neonate, neonatal alloimmune thrombocytopenic purpura, or transfusion-associated lung injury in a patient or transfusion recipient.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: June 9, 2015
    Assignee: NEW YORK BLOOD CENTER, INC.
    Inventor: Gregory R. Halverson
  • Antibodies, systems and methods for determining relative hemolytic index
    Patent number: 8426210
    Abstract: Disclosed herein are antibodies, systems and methods for assessing the risk of hemolysis following a blood transfusion with crossmatch incompatible blood. The disclosure provides a method for determining the relative hemolytic index and therefore the risk of post-transfusion hemolysis for said patient.
    Type: Grant
    Filed: October 20, 2010
    Date of Patent: April 23, 2013
    Assignee: New York Blood Center, Inc.
    Inventor: Gregory R. Halverson
  • ANTIBODIES, SYSTEMS AND METHODS FOR DETERMINING RELATIVE HEMOLYTIC INDEX
    Publication number: 20110091911
    Abstract: Disclosed herein are antibodies, systems and methods for assessing the risk of hemolysis following a blood transfusion with crossmatch incompatible blood. The disclosure provides a method for determining the relative hemolytic index and therefore the risk of post-transfusion hemolysis for said patient.
    Type: Application
    Filed: October 20, 2010
    Publication date: April 21, 2011
    Applicant: New York Blood Center, Inc.
    Inventor: Gregory R. Halverson